The adverse pharmacology of calcineurin inhibitors and their impact on hepatitis C recurrence after liver transplantation: implications for clinical practice.

Find People
Find Everything
About This Site
Edit My Profile
Login to Profiles
DIRECT2Experts
Help / FAQ

Announcement

You can now add alternative names! Click here to add other names that you've published under.

The adverse pharmacology of calcineurin inhibitors and their impact on hepatitis C recurrence after liver transplantation: implications for clinical practice.

Garcia-Saenz-de-Sicilia M, Mukherjee S. The adverse pharmacology of calcineurin inhibitors and their impact on hepatitis C recurrence after liver transplantation: implications for clinical practice. Expert Rev Clin Pharmacol. 2012 Sep; 5(5):587-93.

View in: PubMed

subject areas

Cyclosporine
Graft Rejection
Hepacivirus
Hepatitis C
Humans
Immunosuppressive Agents
Liver Transplantation
Randomized Controlled Trials as Topic
Recurrence

authors with profiles

Mauricio Garcia Saenz De Sicil